BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: May Fulton C, Bailey WJ. Live Viral Vaccine Neurovirulence Screening: Current and Future Models. Vaccines (Basel) 2021;9:710. [PMID: 34209433 DOI: 10.3390/vaccines9070710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Ren R, Ma B, Xie J, Ma Y, Luo H, Guo Y, Ding L, Zhang L, Zhang M, Wang T, Shuang Z, Zhu X. Comparative Study on MNVT of OPV Type I and III Reference Products in Different Periods. Diseases 2023;11. [PMID: 36810542 DOI: 10.3390/diseases11010028] [Reference Citation Analysis]
2 Monath TP, Nichols R, Tussey L, Scappaticci K, Pullano TG, Whiteman MD, Vasilakis N, Rossi SL, Campos RK, Azar SR, Spratt HM, Seaton BL, Archambault WT, Costecalde YV, Moore EH, Hawks RJ, Fusco J. Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential. PLoS Pathog 2022;18:e1010658. [DOI: 10.1371/journal.ppat.1010658] [Reference Citation Analysis]